AP
GILD icon

AHL Partners’s Gilead Sciences GILD Stock Holding History

AHL Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$8.21M Buy
114,529
+25,119
+28% +$1.91M 0.13% 288
2017
Q3 		$7.24M Buy
89,410
+19,183
+27% +$1.47M 0.13% 283
2017
Q2 		$4.97M Buy
70,227
+11,337
+19% +$754K 0.11% 353
2017
Q1 		$4M Buy
58,890
+15,839
+37% +$1.11M 0.09% 413
2016
Q4 		$3.08M Buy
43,051
+23,692
+122% +$1.76M 0.09% 397
2016
Q3 		$1.53M Buy
19,359
+7,021
+57% +$570K 0.06% 460
2016
Q2 		$1.03M Buy
12,338
+4,391
+55% +$390K 0.06% 430
2016
Q1 		$730K Sell
7,947
-21,302
-73% -$1.92M 0.05% 470
2015
Q4 		$2.96M Buy
29,249
+22,756
+350% +$2.37M 0.23% 154
2015
Q3 		$638K Sell
6,493
-40,220
-86% -$4.47M 0.1% 288
2015
Q2 		$5.47M Sell
46,713
-9,729
-17% -$1.06M 0.22% 142
2015
Q1 		$5.54M Buy
56,442
+29,811
+112% +$3.03M 0.22% 129
2014
Q4 		$2.51M Buy
26,631
+24,398
+1,093% +$2.52M 0.13% 345
2014
Q3 		$238K Buy
+2,233
New +$219K 0.02% 657

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AHL Partners's GILD Position: Q4 2017 in Review

AHL Partners increased its Gilead Sciences (GILD) stake by 28% in Q4 2017, buying an estimated $1.91M and bringing the position to 114,529 shares worth $8.21M. The position accounts for 0.13% of the portfolio, ranked #288.

AHL Partners first reported a position in GILD in Q3 2014 and has held it in 14 quarters since. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • AHL Partners held 114,529 shares of Gilead Sciences worth $8.21M as of Q4 2017.
  • AHL Partners bought 25,119 Gilead Sciences shares in Q4 2017, an estimated $1.91M.
  • Gilead Sciences made up 0.13% of AHL Partners's portfolio in Q4 2017, its #288 holding.
  • AHL Partners first reported a position in Gilead Sciences in Q3 2014 and has held it in 14 quarters since.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.